Chronic Insomnia Disorder clinical trials

Explore recruiting chronic insomnia disorder clinical trials.

Recruiting chronic insomnia disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Insomnia Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DARIdorexant efficacy on the COGnitive performance in patients with chronic insomnia disorder. DARI-COG Study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Chronic Insomnia Disorder trials by city

Chronic Insomnia Disorder in Toronto Chronic Insomnia Disorder in Vancouver Chronic Insomnia Disorder in Montreal Chronic Insomnia Disorder in Calgary Chronic Insomnia Disorder in Edmonton Chronic Insomnia Disorder in Ottawa Chronic Insomnia Disorder in Winnipeg Chronic Insomnia Disorder in Quebec City Chronic Insomnia Disorder in Hamilton Chronic Insomnia Disorder in Kitchener Chronic Insomnia Disorder in London Chronic Insomnia Disorder in Halifax Chronic Insomnia Disorder in New York Chronic Insomnia Disorder in Los Angeles Chronic Insomnia Disorder in Chicago Chronic Insomnia Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease